Works matching AU Yust-Katz, Shlomit


Results: 41
    1
    2
    3

    Osimertinib in advanced EGFR-mutant lung adenocarcinoma with asymptomatic brain metastases: an open-label, 3-arm, phase II pilot study.

    Published in:
    Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdab188
    By:
    • Peled, Nir;
    • Kian, Waleed;
    • Inbar, Edna;
    • Goldstein, Iris M.;
    • Zemel, Melanie;
    • Rotem, Ofer;
    • Rozenblum, Anna B.;
    • Nechushtan, Hovav;
    • Dudnik, Elizabeth;
    • Levin, Daniel;
    • Zer, Alona;
    • Keren-Rosenberg, Shoshana;
    • Yust-Katz, Shlomit;
    • Fuchs, Vered;
    • Remilah, Areen A.;
    • Shelef, Ilan;
    • Roisman, Laila C.
    Publication type:
    Article
    4
    5
    6
    7

    Venous thromboembolism (VTE) and glioblastoma.

    Published in:
    Journal of Neuro-Oncology, 2015, v. 124, n. 1, p. 87, doi. 10.1007/s11060-015-1805-2
    By:
    • Yust-Katz, Shlomit;
    • Mandel, Jacob;
    • Wu, Jimin;
    • Yuan, Ying;
    • Webre, Courtney;
    • Pawar, Tushar;
    • Lhadha, Harshad;
    • Gilbert, Mark;
    • Armstrong, Terri
    Publication type:
    Article
    8
    9
    10
    11
    12

    Height in adolescence as a risk factor for glioma subtypes: a nationwide retrospective cohort study of 2.2 million subjects.

    Published in:
    Neuro-Oncology, 2021, v. 23, n. 8, p. 1383, doi. 10.1093/neuonc/noab049
    By:
    • Tschernichovsky, Roi;
    • Katz, Lior H;
    • Derazne, Estela;
    • Berliner, Matan Ben-Zion;
    • Simchoni, Maya;
    • Levine, Hagai;
    • Keinan-Boker, Lital;
    • Benouaich-Amiel, Alexandra;
    • Kanner, Andrew A;
    • Laviv, Yosef;
    • Honig, Asaf;
    • Dudnik, Elizabeth;
    • Siegal, Tali;
    • Mandel, Jacob;
    • Twig, Gilad;
    • Yust-Katz, Shlomit
    Publication type:
    Article
    13
    14

    Safety and efficacy of VB-111, an anticancer gene therapy, in patients with recurrent glioblastoma: results of a phase I/II study.

    Published in:
    Neuro-Oncology, 2020, v. 22, n. 5, p. 694, doi. 10.1093/neuonc/noz231
    By:
    • Brenner, Andrew J;
    • Peters, Katherine B;
    • Vredenburgh, James;
    • Bokstein, Felix;
    • Blumenthal, Deborah T;
    • Yust-Katz, Shlomit;
    • Peretz, Idit;
    • Oberman, Bernice;
    • Freedman, Laurence S;
    • Ellingson, Benjamin M;
    • Cloughesy, Timothy F;
    • Sher, Naamit;
    • Cohen, Yael C;
    • Lowenton-Spier, Noa;
    • Minei, Tamar Rachmilewitz;
    • Yakov, Niva;
    • Mendel, Itzhak;
    • Breitbart, Eyal;
    • Wen, Patrick Y
    Publication type:
    Article
    15
    16
    17
    18
    19

    Pregnancy and glial brain tumors.

    Published in:
    Neuro-Oncology, 2014, v. 16, n. 9, p. 1289, doi. 10.1093/neuonc/nou019
    By:
    • Yust-Katz, Shlomit;
    • de Groot, John F.;
    • Liu, Diane;
    • Wu, Jimin;
    • Yuan, Ying;
    • Anderson, Mark D.;
    • Conrad, Charles A.;
    • Milbourne, Andrea;
    • Gilbert, Mark R.;
    • Armstrong, Terri S.
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27

    Brain metastasis in gastroesophageal adenocarcinoma and HER2 status.

    Published in:
    Journal of Neuro-Oncology, 2018, v. 138, n. 2, p. 315, doi. 10.1007/s11060-018-2798-4
    By:
    • Limon, Dror;
    • Gal, Omer;
    • Gordon, Noa;
    • Katz, Lior;
    • Perl, Gali;
    • Purim, Ofer;
    • Amit, Limor;
    • Stemmer, Salomon M.;
    • Kundel, Yulia;
    • Ben-Aharon, Irit;
    • Brenner, Baruch;
    • Siegal, Tali;
    • Yust-Katz, Shlomit
    Publication type:
    Article
    28

    Neurologic complications of immune checkpoint inhibitors.

    Published in:
    Journal of Neuro-Oncology, 2018, v. 137, n. 3, p. 601, doi. 10.1007/s11060-018-2752-5
    By:
    • Fellner, Avi;
    • Makranz, Chen;
    • Lotem, Michal;
    • Bokstein, Felix;
    • Taliansky, Alisa;
    • Rosenberg, Shai;
    • Blumenthal, Deborah T.;
    • Mandel, Jacob;
    • Fichman, Suzana;
    • Kogan, Elena;
    • Steiner, Israel;
    • Siegal, Tali;
    • Lossos, Alexander;
    • Yust-Katz, Shlomit
    Publication type:
    Article
    29
    30
    31

    The CT halo sign in invasive aspergillosis.

    Published in:
    Clinical Case Reports, 2014, v. 2, n. 3, p. 113, doi. 10.1002/ccr3.67
    By:
    • Shroff, Sheetal;
    • Shroff, Girish S.;
    • Yust‐Katz, Shlomit;
    • Olar, Adriana;
    • Tummala, Sudhakar;
    • Tremont‐Lukats, Ivo W.
    Publication type:
    Article
    32
    33

    Prevalence of pathogenic germline variants in adult-type diffuse glioma.

    Published in:
    Neuro-Oncology Practice, 2023, v. 10, n. 5, p. 482, doi. 10.1093/nop/npad033
    By:
    • McDonald, Malcolm F;
    • Prather, Lyndsey L;
    • Helfer, Cassandra R;
    • Ludmir, Ethan B;
    • Echeverria, Alfredo E;
    • Yust-Katz, Shlomit;
    • Patel, Akash J;
    • Deneen, Benjamin;
    • Rao, Ganesh;
    • Jalali, Ali;
    • Dhar, Shweta U;
    • Amos, Chris I;
    • Mandel, Jacob J
    Publication type:
    Article
    34
    35

    Molecular Subtypes of Glioblastoma Are Relevant to Lower Grade Glioma.

    Published in:
    PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0091216
    By:
    • Guan, Xiaowei;
    • Vengoechea, Jaime;
    • Zheng, Siyuan;
    • Sloan, Andrew E.;
    • Chen, Yanwen;
    • Brat, Daniel J.;
    • O’Neill, Brian Patrick;
    • de Groot, John;
    • Yust-Katz, Shlomit;
    • Yung, Wai-Kwan Alfred;
    • Cohen, Mark L.;
    • Aldape, Kenneth D.;
    • Rosenfeld, Steven;
    • Verhaak, Roeland G. W.;
    • Barnholtz-Sloan, Jill S.
    Publication type:
    Article
    36
    37

    A phase 2 study of ibrutinib maintenance following first‐line high‐dose methotrexate‐based chemotherapy for elderly patients with primary central nervous system lymphoma.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 24, p. 3905, doi. 10.1002/cncr.34985
    By:
    • Bairey, Osnat;
    • Taliansky, Alisa;
    • Glik, Amir;
    • Amiel, Alexandra;
    • Yust‐Katz, Shlomit;
    • Gurion, Ronit;
    • Zektser, Miri;
    • Porges, Tzvika;
    • Sarid, Nadav;
    • Horowitz, Netanel A.;
    • Shina, Tzahala Tzuk;
    • Lebel, Eyal;
    • Cohen, Amos;
    • Geiger, Karyn Revital;
    • Raanani, Pia;
    • Wolach, Ofir;
    • Siegal, Tali
    Publication type:
    Article
    38
    39

    Taxane versus vinorelbine in combination with trastuzumab and pertuzumab for first-line treatment of metastatic HER2-positive breast cancer: a retrospective two-center study.

    Published in:
    Breast Cancer Research & Treatment, 2021, v. 188, n. 2, p. 379, doi. 10.1007/s10549-021-06198-4
    By:
    • Reinhorn, Daniel;
    • Kuchuk, Iryna;
    • Shochat, Tzippy;
    • Nisenbaum, Bella;
    • Sulkes, Aaron;
    • Hendler, Daniel;
    • Rotem, Ofer;
    • Tsoref, Daliah;
    • Olitzky, Olga;
    • Goldvaser, Hadar;
    • Sarfaty, Michal;
    • Neiman, Victoria;
    • Prus, Judit;
    • Gottfried, Maya;
    • Yust-Katz, Shlomit;
    • Yerushalmi, Rinat
    Publication type:
    Article
    40
    41